TY - JOUR
T1 - Angiotensin-converting enzyme insertion or deletion dimorphism in predisposition to cardiovascular diseases amongst United Arab Emirates nationals
AU - Frossard, P. M.
AU - Bokhari, A. M.
AU - Elshahat, Y. I.
AU - Lestringant, G. G.
AU - John, A. M.
AU - Hill, S. H.
AU - Abdulle, A. M.
AU - Obineche, E. N.
PY - 1998
Y1 - 1998
N2 - Objectives: The absence of a 287 base pairs Alu sequence in the angiotensin-converting enzyme gene (D allele) is associated with higher angiotensin converting enzyme levels than its presence (I allele). There is, however, a huge body of conflicting reports that have linked angiotensin-converting enzyme insertion/deletion to hypertension, ischaemic heart disease, myocardial infarction, left ventricular hypertrophy, as well as several other clinical entities. We carried out a retrospective, case-control study of the angiotensin-converting enzyme insertion/deletion dimorphism in relation to circulating angiotensin-converting enzyme activity, as well as to hypertention, ischemic heart disease, myocardial infaction and left ventricular hypertrophy, amongst United Arab Emirates nationals subjects (Emirati). Methods: We investigated a sample population of 285 Emirati comprising groups of controls and of patients with clinical diagnoses of hypertension, ischaemic heart disease, myocardial infaction and left ventricular hypertrophy. Angiotensin-converting enzyme insertion/deletion genotypes were determined by assays based on polymerase chain reaction. Results: The D allele was associated with increased circulating angiotensin-converting enzyme activity, and the angiotensin-converting enzyme insertion/deletion marker accounted for 28% of the variance of the phenomenon determining angiotensin-converting enzyme levels. We found, however, no association between angiotensin-converting enzyme insertion/deletion and clinical diagnoses of hypertension, ischaemic heart disease, myocardial infarction and left ventricular hypertrophy. Conclusion: Although the D allele of the angiotensin converting enzyme insertion/deletion dimorphism tracks with circulating angiotensin-converting enzyme activities in United Arab Emirates nationals, it does not constitute a predictive marker for CVDs in this population.
AB - Objectives: The absence of a 287 base pairs Alu sequence in the angiotensin-converting enzyme gene (D allele) is associated with higher angiotensin converting enzyme levels than its presence (I allele). There is, however, a huge body of conflicting reports that have linked angiotensin-converting enzyme insertion/deletion to hypertension, ischaemic heart disease, myocardial infarction, left ventricular hypertrophy, as well as several other clinical entities. We carried out a retrospective, case-control study of the angiotensin-converting enzyme insertion/deletion dimorphism in relation to circulating angiotensin-converting enzyme activity, as well as to hypertention, ischemic heart disease, myocardial infaction and left ventricular hypertrophy, amongst United Arab Emirates nationals subjects (Emirati). Methods: We investigated a sample population of 285 Emirati comprising groups of controls and of patients with clinical diagnoses of hypertension, ischaemic heart disease, myocardial infaction and left ventricular hypertrophy. Angiotensin-converting enzyme insertion/deletion genotypes were determined by assays based on polymerase chain reaction. Results: The D allele was associated with increased circulating angiotensin-converting enzyme activity, and the angiotensin-converting enzyme insertion/deletion marker accounted for 28% of the variance of the phenomenon determining angiotensin-converting enzyme levels. We found, however, no association between angiotensin-converting enzyme insertion/deletion and clinical diagnoses of hypertension, ischaemic heart disease, myocardial infarction and left ventricular hypertrophy. Conclusion: Although the D allele of the angiotensin converting enzyme insertion/deletion dimorphism tracks with circulating angiotensin-converting enzyme activities in United Arab Emirates nationals, it does not constitute a predictive marker for CVDs in this population.
KW - Angiotensin-converting enzyme
KW - Cardiovascular diseases
KW - Genetics
KW - Hypertension
KW - Myocardial infarction
KW - Polymerase chain reaction
UR - http://www.scopus.com/inward/record.url?scp=2442615017&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2442615017&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:2442615017
SN - 0379-5284
VL - 19
SP - 713
EP - 719
JO - Saudi Medical Journal
JF - Saudi Medical Journal
IS - 6
ER -